1st Quarter - Report

MAYO CLINIC for MAYO CLINIC

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Transportation TRA

Funding opportunities and planned improvements for the Rochester International Airport

LobbyistCovered position, as disclosed
SARAH CURTIS Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; White House Office; Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; SENATE

Veterans VET

Reimbursement and coverage issues related to VA health care and Tricare

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Food & Drug Administration (FDA); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Pharmacy PHA

Drug shortages; drug pricing; 340B Program

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Office of the Vice President of the United States; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Science/Technology SCI

Telemedicine technology; New diagnostic tests, Precision medicine; NextGen sequencing

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; White House Office; Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: White House Office; Food & Drug Administration (FDA); Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6201 (116th), H.R. 6074 (116th), H.R. 748 (116th)

Medical/Disease Research/Clinical Labs MED

Reimbursements and lab payments including PAMA and S. 6102, the Verifying Accurate Leading-edge IVCT Development Act of 2020; Regulation of and reimbursements for testing related to COVID-19; Medical research funding; Regulatory relief; Laboratory diagnostic tests; Rural health

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; SENATE; White House Office

Bills named: S. 6102 (116th)

Health Issues HCR

Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: White House Office; Food & Drug Administration (FDA); SENATE; Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP)

Bills named: H.R. 6074 (116th), H.R. 748 (116th), H.R. 6201 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.